Artículos Científicos

Home , Feline vaccination

Editor: NOEL GONZÁLEZ GOTERA Número 115 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 211213 – 271213 Fotos: Dra. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre 20 y el 27 de diciembre de 2013. Con “vaccin*” en título: 104 artículos recuperados.

Vacunas Meningococo (Neisseria meningitidis)

45. EpiReview: Meningococcal disease in NSW, 1991-2011: trends in relation to meningococcal C vaccination.

Passmore E, Ferson MJ, Tobin S.

N S W Public Health Bull. 2013 Dec;24(2-3):119-24. doi: 10.1071/NB12121.

PMID: 24360208 [PubMed - in process]

Related citations

Select item 24359994

89. MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers.

Hale SF, Camaione L, Lomaestro BM.

Ann Pharmacother. 2013 Dec 18. [Epub ahead of print]

PMID: 24353263 [PubMed - as supplied by publisher]

Related citations

Select item 24352476

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

5. Tuberculosis Screening by Tuberculosis Skin Test or QuantiFERON®-TB Gold In-Tube Assay among an Immigrant Population with a High Prevalence of Tuberculosis and BCG Vaccination.

Painter JA, Graviss EA, Hai HH, Nhung DT, Nga TT, Ha NP, Wall K, Loan le TH, Parker M, Manangan L, O'Brien R, Maloney SA, Hoekstra RM, Reves R.

PLoS One. 2013 Dec 19;8(12):e82727. doi: 10.1371/journal.pone.0082727.

PMID: 24367546 [PubMed - in process] Free Article

Related citations

Select item 24367252

24. Correction: A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses.

Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M.

PLoS One. 2013 Dec 17;8(12). doi: 10.1371/annotation/81a1f333-7fb3-4afd-b158- 94774d5522fa.

PMID: 24363799 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 24363764

Vacunas Neumococo (Streptococcus pneumoniae)

63. Safety and immunogenicity of 10-valent pneumococcal nontypeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2- dose catch-up regimens in the second year of life.

Odusanya OO, Kuyinu YA, Kehinde OA, Shafi F, François N, Yarzabal JP, Dobbelaere K, Rüggeberg JU, Borys D, Schuerman L.

Hum Vaccin Immunother. 2013 Dec 4;10(3). [Epub ahead of print]

PMID: 24356787 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24356698

104. Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.

Tatochenko V, Sidorenko S, Namazova-Baranova L, Mayanskiy N, Kulichenko T, Baranov A, Lobzin Y, Kharit S, Kozlov R, Andreeva I, Muravjev A, Chagaryan A, Koroleva I, Beloshitskiy G, Mironov K, Degtyareva E, Reinert RR.

Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print]

PMID: 24350587 [PubMed - as supplied by publisher]

Related citations

Vacuna Tuberculosis (Mycobacterium tuberculosis)

43. Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: A discussion of the adaptive licensure concept.

Rustomjee R, Lockhart S, Shea J, Fourie PB, Hindle Z, Steel G, Hussey G, Ginsberg A, Brennan MJ.

Tuberculosis (Edinb). 2013 Dec 8. pii: S1472-9792(13)00197-2. doi: 10.1016/j.tube.2013.11.002. [Epub ahead of print]

PMID: 24360811 [PubMed - as supplied by publisher]

Related citations

Select item 24360409

102. High Mobility group box 1 (HMGB1) acts as an adjuvant for tuberculosis subunit vaccines.

Grover A, Troudt J, Foster C, Basaraba R, Izzo A.

Immunology. 2013 Dec 18. doi: 10.1111/imm.12236. [Epub ahead of print]

PMID: 24350616 [PubMed - as supplied by publisher]

Related citations

Select item 24350614

Vacunas Cólera (Vibrio cholerae)

2. Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study.

Chawley P, Samal HB, Prava J, Suar M, Mahapatra RK.

Genomics. 2013 Dec 21. pii: S0888-7543(13)00227-9. doi: 10.1016/j.ygeno.2013.12.002. [Epub ahead of print]

PMID: 24368230 [PubMed - as supplied by publisher]

Related citations

Select item 24368086

88. Correction: Cholera Vaccination Campaign Contributes to Improved Knowledge Regarding Cholera and Improved Practice Relevant to Waterborne Disease in Rural Haiti.

Aibana O, Franke MF, Teng JE, Hilaire J, Raymond M, Ivers LC.

PLoS Negl Trop Dis. 2013 Dec 13;7(12). doi: 10.1371/annotation/13f018ff-b71a-4c5e-a276- d4b4ae608fee.

PMID: 24353756 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 24353263

Vacunas, otras

1. Previous history and cigarette smoking as interfering factors for the effect of vaccine on human papillomavirus infection.

Pei H, Yu Q, Xue Q, Wei F, Tao L.

J Infect Dis. 2013 Dec 23. [Epub ahead of print] No abstract available.

PMID: 24368835 [PubMed - as supplied by publisher]

Related citations

Select item 24368230 2.

Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study.

Chawley P, Samal HB, Prava J, Suar M, Mahapatra RK.

Genomics. 2013 Dec 21. pii: S0888-7543(13)00227-9. doi: 10.1016/j.ygeno.2013.12.002. [Epub ahead of print]

PMID: 24368230 [PubMed - as supplied by publisher]

Related citations

Select item 24368086 3.

Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers.

Palya V, Tatár-Kis T, Mató T, Felföldi B, Kovács E, Gardin Y.

Vet Immunol Immunopathol. 2013 Dec 1. pii: S0165-2427(13)00314-0. doi: 10.1016/j.vetimm.2013.11.008. [Epub ahead of print]

PMID: 24368086 [PubMed - as supplied by publisher]

Related citations

Select item 24367715 4.

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates againstBundibugyo ebolavirus.

Mire CE, Geisbert JB, Marzi A, Agans KN, Feldmann H, Geisbert TW.

PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2600. doi: 10.1371/journal.pntd.0002600.

PMID: 24367715 [PubMed - in process] Free Article

Related citations

Select item 24367546 5.

Tuberculosis Screening by Tuberculosis Skin Test or QuantiFERON®-TB Gold In-Tube Assay among an Immigrant Population with a High Prevalence of Tuberculosis and BCG Vaccination.

Painter JA, Graviss EA, Hai HH, Nhung DT, Nga TT, Ha NP, Wall K, Loan le TH, Parker M, Manangan L, O'Brien R, Maloney SA, Hoekstra RM, Reves R.

PLoS One. 2013 Dec 19;8(12):e82727. doi: 10.1371/journal.pone.0082727.

PMID: 24367546 [PubMed - in process] Free Article

Related citations

Select item 24367252 6.

Novel Strategies to Enhance Vaccine Immunity against Coccidioidomycosis.

Cole GT, Hung CY, Sanderson SD, Hurtgen BJ, Wüthrich M, Klein BS, Deepe GS, Ostroff GR, Levitz SM.

PLoS Pathog. 2013 Dec;9(12):e1003768. doi: 10.1371/journal.ppat.1003768. Epub 2013 Dec 19. No abstract available.

PMID: 24367252 [PubMed - in process] Free Article

Related citations

Select item 24367232 7.

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina.

Espul C, Benedetti L, Cuello H, Houillon G, Rasuli A.

Hepat Med. 2012 Aug 28;4:53-60. doi: 10.2147/HMER.S33847.

PMID: 24367232 [PubMed]

Related citations

Select item 24367225 8.

Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program.

Cervio G, Trentadue J, D'Agostino D, Luque C, Giorgi M, Armoni J, Debbag R.

Hepat Med. 2011 Sep 19;3:99-106. doi: 10.2147/HMER.S22309.

PMID: 24367225 [PubMed]

Related citations

Select item 24367164 9.

Progress in the development of a therapeutic vaccine for breast cancer.

Coveler AL, Bates NE, Disis ML.

Breast Cancer (Dove Med Press). 2010 Jun 4;2:25-36. Review.

PMID: 24367164 [PubMed - as supplied by publisher]

Related citations

Select item 24367114 10.

Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination.

Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiébaut R, Tibshirani RJ, Davis MM.

Proc Natl Acad Sci U S A. 2013 Dec 23. [Epub ahead of print]

PMID: 24367114 [PubMed - as supplied by publisher]

Related citations

Select item 24367038 11.

Community Circulation Patterns of Oral Polio Vaccine Serotypes 1, 2, and 3 after Mexican National Immunization Weeks.

Troy S, Ferreyra-Reyes L, Huang C, Sarnquist C, Canizales-Quintero S, Nelson C, Báez- Saldaña R, Holubar M, Ferreira-Guerrero E, García-García L, Maldonado Y.

J Infect Dis. 2013 Dec 23. [Epub ahead of print]

PMID: 24367038 [PubMed - as supplied by publisher]

Related citations

Select item 24366664 12.

IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.

Yamaki K, Nakashima T, Miyatake K, Ishibashi Y, Ito A, Kuranishi A, Taguchi A, Morioka A, Yamamoto M, Yoshino S.

Immunol Res. 2013 Dec 24. [Epub ahead of print]

PMID: 24366664 [PubMed - as supplied by publisher]

Related citations

Select item 24366025 13.

Designing and Evaluating a Health Belief Model-Based Intervention to Increase Intent of HPV Vaccination among College Males.

Mehta P, Sharma M, Lee RC.

Int Q Community Health Educ. 2013;34(1):101-17. doi: 10.2190/IQ.34.1.h.

PMID: 24366025 [PubMed - in process]

Related citations

Select item 24366021 14.

A Recommendation to Use the Diffusion of Innovations Theory to Understand School Nurses' Role in HPV Vaccine Uptake.

Rosen B, Goodson P.

Int Q Community Health Educ. 2013;34(1):37-49. doi: 10.2190/IQ.34.1.d.

PMID: 24366021 [PubMed - in process]

Related citations

Select item 24366008 15.

Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients.

Cowan M, Chon WJ, Desai A, Andrews S, Bai Y, Veguilla V, Katz JM, Josephson MA, Wilson PC, Sciammas R, Chong AS.

Transplantation. 2013 Dec 19. [Epub ahead of print]

PMID: 24366008 [PubMed - as supplied by publisher]

Related citations

Select item 24365998 16.

Hypertension Vaccine may be a boon to millions in developing world.

Bairwa M, Pilania M, Gupta V, Yadav K.

Hum Vaccin Immunother. 2013 Dec 23;10(4). [Epub ahead of print]

PMID: 24365998 [PubMed - as supplied by publisher]

Related citations

Select item 24365968 17.

Obesity vaccines.

Monteiro MP.

Hum Vaccin Immunother. 2013 Dec 23;10(4). [Epub ahead of print] Review.

PMID: 24365968 [PubMed - as supplied by publisher]

Related citations

Select item 24365585 18.

Childhood narcolepsy and H1N1 vaccination: stirring up a sleeping menace?

Nevsimalova S.

Sleep Med. 2013 Nov 20. pii: S1389-9457(13)01210-0. doi: 10.1016/j.sleep.2013.11.004. [Epub ahead of print] No abstract available.

PMID: 24365585 [PubMed - as supplied by publisher]

Related citations

Select item 24365435 19.

Neurologic complications of vaccinations.

Miravalle AA, Schreiner T.

Handb Clin Neurol. 2014;121:1549-57. doi: 10.1016/B978-0-7020-4088-7.00103-6.

PMID: 24365435 [PubMed - in process]

Related citations

Select item 24364988 20.

Catecholamine plasma levels, IFN-γ serum levels and antibodies production induced by rabies vaccine in dogs selected for their paw preference.

Siniscalchi M, Cirone F, Guaricci AC, Quaranta A.

Laterality. 2013 Dec 24. [Epub ahead of print]

PMID: 24364988 [PubMed - as supplied by publisher]

Related citations

21.

ACIP Releases Influenza Vaccination Updates for 2013-2014.

Lambert M.

Am Fam Physician. 2013 Oct 15;88(8):543-50. No abstract available.

PMID: 24364577 [PubMed - in process]

Related citations

Select item 24364139 22.

[A molecular basis of the plague vaccine development].

[No authors listed]

Mol Gen Mikrobiol Virusol. 2013;(3):3-12. Russian.

PMID: 24364139 [PubMed - in process]

Related citations

Select item 24363932 23.

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV- Infected Children and Youth.

Pass RF, Nachman S, Flynn PM, Muresan P, Fenton T, Cunningham CK, Borkowsky W, McAuley JB, Spector SA, Petzold E, Levy W, Siberry GK, Handelsman E, Utech LJ, Weinberg A.

J Pediatric Infect Dis Soc. 2013 Dec;2(4):352-360. Epub 2013 Jul 17.

PMID: 24363932 [PubMed]

Related citations

Select item 24363799 24.

Correction: A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses.

Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M.

PLoS One. 2013 Dec 17;8(12). doi: 10.1371/annotation/81a1f333-7fb3-4afd-b158- 94774d5522fa.

PMID: 24363799 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 24363764 25.

T cell vaccination inhibits th1/th17/tfh frequencies and production of autoantibodies in collagen-induced arthritis.

Li S, Niu X, Xi Y, Deng S, Li C, Zhao Q, Chen G.

Clin Dev Immunol. 2013;2013:967301. doi: 10.1155/2013/967301. Epub 2013 Dec 2.

PMID: 24363764 [PubMed - in process] Free PMC Article

Related citations

Select item 24363758 26.

Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer-Results from Phase I Clinical Trials.

Tanaka T, Kitamura H, Inoue R, Nishida S, Takahashi-Takaya A, Kawami S, Torigoe T, Hirohashi Y, Tsukamoto T, Sato N, Masumori N.

Clin Dev Immunol. 2013;2013:262967. doi: 10.1155/2013/262967. Epub 2013 Nov 20.

PMID: 24363758 [PubMed - in process] Free PMC Article

Related citations

Select item 24363656 27.

CD4⁺ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines.

Ciabattini A, Pettini E, Medaglini D.

Front Immunol. 2013 Dec 4;4:421. Review.

PMID: 24363656 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 24363436 28.

Antibody response to influenza A (H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.

Gaglani M, Spencer S, Ball S, Song J, Naleway A, Henkle E, Bozeman S, Reynolds S, Sessions W, Hancock K, Thompson M.

J Infect Dis. 2013 Dec 19. [Epub ahead of print]

PMID: 24363436 [PubMed - as supplied by publisher]

Related citations

Select item 24362701 29.

Challenges and opportunities for respiratory syncytial virus vaccines.

Graham BS, Anderson LJ.

Curr Top Microbiol Immunol. 2013;372:391-404. doi: 10.1007/978-3-642-38919- 1_20.

PMID: 24362701 [PubMed - in process]

Related citations

Select item 24362696 30.

Gene-based vaccine approaches for respiratory syncytial virus.

Loomis RJ, Johnson PR.

Curr Top Microbiol Immunol. 2013;372:307-24. doi: 10.1007/978-3-642-38919-1_15.

PMID: 24362696 [PubMed - in process]

Related citations

Select item 24362695 31.

Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.

Morrison TG, Walsh EE.

Curr Top Microbiol Immunol. 2013;372:285-306. doi: 10.1007/978-3-642-38919- 1_14.

PMID: 24362695 [PubMed - in process]

Related citations

Select item 24362694 32.

Live-attenuated respiratory syncytial virus vaccines.

Karron RA, Buchholz UJ, Collins PL.

Curr Top Microbiol Immunol. 2013;372:259-84. doi: 10.1007/978-3-642-38919-1_13.

PMID: 24362694 [PubMed - in process]

Related citations

Select item 24362099 33.

Total mercury content in canine hair before and after administration of vaccines containing thiomersal.

Sedlackova L, Kral T, Sevcikova M, Kruzikova K, Svobodova Z.

Neuro Endocrinol Lett. 2013 Nov 23;34(Suppl2):90-94. [Epub ahead of print]

PMID: 24362099 [PubMed - as supplied by publisher]

Related citations

Select item 24361951 34.

2013 AAFP Feline Vaccination Advisory Panel Report.

Scherk MA, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Lappin MR, Levy JK, Little SE, Nordone SK, Sparkes AH.

J Feline Med Surg. 2014 Jan;16(1):66. doi: 10.1177/1098612X13519377.

PMID: 24361951 [PubMed - in process]

Related citations

Select item 24361852 35.

Lack of Persistence of Influenza Vaccine Antibody Titers in Patients with Heart Failure.

Albrecht CM, Sweitzer NK, Johnson MR, Vardeny O.

J Card Fail. 2013 Dec 18. pii: S1071-9164(13)01280-3. doi: 10.1016/j.cardfail.2013.12.008. [Epub ahead of print]

PMID: 24361852 [PubMed - as supplied by publisher]

Related citations

Select item 24361819 36.

Perspectives in vaccine adjuvants for allergen-specific immunotherapy.

Filì L, Cardilicchia E, Maggi E, Parronchi P.

Immunol Lett. 2013 Dec 19. pii: S0165-2478(13)00225-3. doi: 10.1016/j.imlet.2013.12.011. [Epub ahead of print]

PMID: 24361819 [PubMed - as supplied by publisher]

Related citations

Select item 24361732 37.

Pharmacist Authority to Provide HPV Vaccine: Novel Partners in Cervical Cancer Prevention.

Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS.

Gynecol Oncol. 2013 Dec 18. pii: S0090-8258(13)01384-X. doi: 10.1016/j.ygyno.2013.12.020. [Epub ahead of print]

PMID: 24361732 [PubMed - as supplied by publisher]

Related citations

Select item 24361548 38.

Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-Synuclein: Feasibility study.

Ghochikyan A, Petrushina I, Davtyan H, Hovakimyan A, Saing T, Davtyan A, Cribbs DH, Agadjanyan MG.

Neurosci Lett. 2013 Dec 19. pii: S0304-3940(13)01109-9. doi: 10.1016/j.neulet.2013.12.028. [Epub ahead of print]

PMID: 24361548 [PubMed - as supplied by publisher]

Related citations

Select item 24361495 39.

The Schedule Effect: can recurrent peak infections be reduced without vaccines, quarantines or school closings?

Diedrichs DR, Isihara PA, Buursma DD.

Math Biosci. 2013 Dec 18. pii: S0025-5564(13)00275-7. doi: 10.1016/j.mbs.2013.12.004. [Epub ahead of print]

PMID: 24361495 [PubMed - as supplied by publisher]

Related citations

Select item 24360892 40.

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.

Barker CI, Snape MD.

Lancet Infect Dis. 2013 Dec 18. pii: S1473-3099(13)70238-X. doi: 10.1016/S1473- 3099(13)70238-X. [Epub ahead of print]

PMID: 24360892 [PubMed - as supplied by publisher]

Related citations

Select item 24360890 41.

Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine- induced immune responses in older individuals.

Ovsyannikova IG, White SJ, Larrabee BR, Grill DE, Jacobson RM, Poland GA.

Vaccine. 2013 Dec 17. pii: S0264-410X(13)01723-4. doi: 10.1016/j.vaccine.2013.12.009. [Epub ahead of print]

PMID: 24360890 [PubMed - as supplied by publisher]

Related citations

Select item 24360847 42.

Budget Impact and Cost-Utility Analysis of Universal Infant Rotavirus Vaccination in Spain.

Imaz I, Rubio B, Cornejo AM, González-Enríquez J.

Prev Med. 2013 Dec 17. pii: S0091-7435(13)00483-0. doi: 10.1016/j.ypmed.2013.12.013. [Epub ahead of print]

PMID: 24360847 [PubMed - as supplied by publisher]

Related citations

Select item 24360811 43.

Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: A discussion of the adaptive licensure concept.

Rustomjee R, Lockhart S, Shea J, Fourie PB, Hindle Z, Steel G, Hussey G, Ginsberg A, Brennan MJ.

Tuberculosis (Edinb). 2013 Dec 8. pii: S1472-9792(13)00197-2. doi: 10.1016/j.tube.2013.11.002. [Epub ahead of print]

PMID: 24360811 [PubMed - as supplied by publisher]

Related citations

Select item 24360409 44.

Hepatitis B vaccination policies for student healthcare workers in Europe.

De Schryver A, Claesen B, Meheus A, Hambach R, van Sprundel M, François G.

J Hosp Infect. 2013 Dec 1. pii: S0195-6701(13)00384-8. doi: 10.1016/j.jhin.2013.11.005. [Epub ahead of print]

PMID: 24360409 [PubMed - as supplied by publisher]

Related citations

Select item 24360208 45.

EpiReview: Meningococcal disease in NSW, 1991-2011: trends in relation to meningococcal C vaccination.

Passmore E, Ferson MJ, Tobin S.

N S W Public Health Bull. 2013 Dec;24(2-3):119-24. doi: 10.1071/NB12121.

PMID: 24360208 [PubMed - in process]

Related citations

Select item 24359994 46.

Comparision of a serological potency assay for furunculosis vaccines (Aeromonas salmonicida subsp. salmonicida) to intraperitoneal challenge in Atlantic salmon (Salmo salar L.).

Romstad AB, Reitan LJ, Midtlyng P, Gravningen K, Emilsen V, Evensen O.

Biologicals. 2013 Dec 18. pii: S1045-1056(13)00141-3. doi: 10.1016/j.biologicals.2013.11.007. [Epub ahead of print]

PMID: 24359994 [PubMed - as supplied by publisher]

Related citations

Select item 24359420 47.

Pre-Exposure Rabies Vaccination among US International Travelers: Findings from the Global TravEpiNet Consortium.

Dolan SB, Jentes ES, Sotir MJ, Han P, Blanton JD, Rao SR, Larocque RC, Ryan And The Global Travepinet Consortium ET.

Vector Borne Zoonotic Dis. 2013 Dec 20. [Epub ahead of print]

PMID: 24359420 [PubMed - as supplied by publisher]

Related citations

Select item 24359402 48.

Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study.

Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS.

BMC Public Health. 2013 Dec 20;13(1):1211. [Epub ahead of print]

PMID: 24359402 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24359340 49.

Development of an improved vaccine for contagious bovine pleuropneumonia: an African perspective on challenges and proposed actions.

Jores J, Mariner JC, Naessens J.

Vet Res. 2013 Dec 20;44(1):122. [Epub ahead of print]

PMID: 24359340 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24359165 50.

Mucosal Vaccination Shapes the Expression of Salivary Antibodies and Establishment of CD8⁺ T-Cells.

Polak D, Benzki-Namdar E, Houri-Haddad Y, Shapira L.

J Periodontol. 2013 Dec 22. [Epub ahead of print]

PMID: 24359165 [PubMed - as supplied by publisher]

Related citations

Select item 24359091 51.

Getting vaccinated or not getting vaccinated?: different reasons for getting vaccinated against seasonal or pandemic influenza.

Bonfiglioli R, Vignoli M, Guglielmi D, Depolo M, Violante FS.

BMC Public Health. 2013 Dec 21;13(1):1221. [Epub ahead of print]

PMID: 24359091 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24359024 52.

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity.

Fung HM, Mikasa TJ, Vergara J, Sivananthan SJ, Guderian JA, Duthie MS, Vedvick TS, Fox CB.

J Nanobiotechnology. 2013 Dec 21;11(1):43. [Epub ahead of print]

PMID: 24359024 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24358990 53.

Parental information-seeking behaviour in childhood vaccinations.

Harmsen IA, Doorman GG, Mollema L, Ruiter RA, Kok G, de Melker HE.

BMC Public Health. 2013 Dec 21;13(1):1219. [Epub ahead of print]

PMID: 24358990 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24358511 54.

A systems framework for vaccine design.

Mooney M, McWeeney S, Canderan G, Sékaly RP.

Curr Opin Immunol. 2013 Oct;25(5):551-5. Review.

PMID: 24358511 [PubMed - in process]

Related citations

Select item 24358361 55.

Identification of cytotoxic T lymphocyte epitopes on Swine viruses: multi-epitope design for universal T cell vaccine.

Liao YC, Lin HH, Lin CH, Chung WB.

PLoS One. 2013 Dec 17;8(12):e84443. doi: 10.1371/journal.pone.0084443.

PMID: 24358361 [PubMed - in process] Free PMC Article

Related citations

Select item 24358333 56.

Community-Based Interventions to Improve HPV Vaccination Coverage among 13- to 15-Year-Old Females: Measures Implemented by Local Governments in Japan.

Fujiwara H, Takei Y, Ishikawa Y, Saga Y, Machida S, Taneichi A, Suzuki M.

PLoS One. 2013 Dec 16;8(12):e84126. doi: 10.1371/journal.pone.0084126.

PMID: 24358333 [PubMed - in process] Free PMC Article

Related citations

Select item 24358269 57.

A Replicating Modified Vaccinia Tiantan Strain Expressing an Avian-Derived Influenza H5N1 Hemagglutinin Induce Broadly Neutralizing Antibodies and Cross-Clade Protective Immunity in Mice.

Xiao H, Liu L, Zhu Q, Tan Z, Yu W, Tang X, Zhan D, Du Y, Wang H, Liu D, Li Z, Yuen KY, Ho DD, Gao GF, Chen Z.

PLoS One. 2013 Dec 17;8(12):e83274. doi: 10.1371/journal.pone.0083274.

PMID: 24358269 [PubMed - in process] Free PMC Article

Related citations

Select item 24357631 58.

Vaccination Against Staphylococcus aureus Pneumonia.

Spaulding AR, Salgado-Pabón W, Merriman JA, Stach CS, Ji Y, Gillman AN, Peterson ML, Schlievert PM.

J Infect Dis. 2013 Dec 19. [Epub ahead of print]

PMID: 24357631 [PubMed - as supplied by publisher]

Related citations

Select item 24357293 59.

2013 Runners-Up. In vaccine design, looks do matter.

[No authors listed]

Science. 2013 Dec 20;342(6165):1442-3. doi: 10.1126/science.342.6165.1442-a. No abstract available.

PMID: 24357293 [PubMed - in process]

Related citations

Select item 24357081 60.

Adjuvant effect of CD40 on H5N1 DNA vaccine in mice.

Chen Q, Zhu G, Wang R, Zhang J, He G.

Arch Virol. 2013 Dec 20. [Epub ahead of print]

PMID: 24357081 [PubMed - as supplied by publisher]

Related citations

Select item 24356965 61.

Characterisation and structure of the vaccinia virus NF-κB antagonist A46.

Fedosyuk S, Grishkovskaya I, De Almeida Ribeiro E Jr, Skern T.

J Biol Chem. 2013 Dec 19. [Epub ahead of print]

PMID: 24356965 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24356806 62.

Attitudes towards vaccination against group B streptococcus in pregnancy.

McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Snape MD.

Arch Dis Child. 2013 Dec 19. doi: 10.1136/archdischild-2013-305716. [Epub ahead of print] No abstract available.

PMID: 24356806 [PubMed - as supplied by publisher]

Related citations

Select item 24356787 63.

Safety and immunogenicity of 10-valent pneumococcal nontypeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.

Odusanya OO, Kuyinu YA, Kehinde OA, Shafi F, François N, Yarzabal JP, Dobbelaere K, Rüggeberg JU, Borys D, Schuerman L.

Hum Vaccin Immunother. 2013 Dec 4;10(3). [Epub ahead of print]

PMID: 24356787 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24356698 64.

Ecological study on mortality from influenza and pneumonia before and after influenza vaccination in the Northeast and South of Brazil.

Oliveira Jde F, Boing AF, Waldman EA, Antunes JL.

Cad Saude Publica. 2013 Dec;29(12):2535-45.

PMID: 24356698 [PubMed - in process] Free Article

Related citations

Select item 24356443 65.

Apropos "Vaccination for safe travel to India"

Arya SC, Agarwal N.

Hum Vaccin Immunother. 2013 Dec 19;10(3). [Epub ahead of print] No abstract available.

PMID: 24356443 [PubMed - as supplied by publisher] 23

Related citations

Select item 24356148 66.

[Age for HPV vaccination: recommandations from the French high council of public health].

Heard I, Floret D.

Med Sci (Paris). 2013 Dec;29(12):1161-6. doi: 10.1051/medsci/20132912021. Epub 2013 Dec 20. French.

PMID: 24356148 [PubMed - in process]

Related citations

Select item 24356147 67.

[Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes].

Louzir H, Aoun K, Späth GF, Laouini D, Prina E, Victoir K, Bouratbine A.

Med Sci (Paris). 2013 Dec;29(12):1151-60. doi: 10.1051/medsci/20132912020. Epub 2013 Dec 20. French.

PMID: 24356147 [PubMed - in process]

Related citations

Select item 24355931 68.

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.

Chen WH, Du L, Chag SM, Ma C, Tricoche N, Tao X, Seid CA, Hudspeth EM, Lustigman S, Tseng CT, Elena Bottazzi M, Hotez PJ, Zhan B, Jiang S.

Hum Vaccin Immunother. 2013 Dec 19;10(3). [Epub ahead of print]

PMID: 24355931 [PubMed - as supplied by publisher]

Related citations

Select item 24355683 69.

Vaccines and pregnancy: Past, present, and future.

Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ.

Semin Fetal Neonatal Med. 2013 Dec 16. pii: S1744-165X(13)00123-6. doi: 10.1016/j.siny.2013.11.014. [Epub ahead of print]

PMID: 24355683 [PubMed - as supplied by publisher]

Related citations

Select item 24355675 70.

Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, Halsey NA, Giuliano AR.

Am J Prev Med. 2014 Jan;46(1):80-4. doi: 10.1016/j.amepre.2013.07.009.

PMID: 24355675 [PubMed - in process]

Related citations

Select item 24355665 71.

Seasonal influenza vaccination at school: a randomized controlled trial.

Humiston SG, Schaffer SJ, Szilagyi PG, Long CE, Chappel TR, Blumkin AK, Szydlowski J, Kolasa MS.

Am J Prev Med. 2014 Jan;46(1):1-9. doi: 10.1016/j.amepre.2013.08.021.

PMID: 24355665 [PubMed - in process]

Related citations

Select item 24355532 72.

Virulence determinants of Salmonella Gallinarum biovar Pullorum identified by PCR signature-tagged mutagenesis and the spiC mutant as a candidate live attenuated vaccine.

Geng S, Jiao X, Barrow P, Pan Z, Chen X.

Vet Microbiol. 2013 Nov 28. pii: S0378-1135(13)00547-6. doi: 10.1016/j.vetmic.2013.11.024. [Epub ahead of print]

PMID: 24355532 [PubMed - as supplied by publisher]

Related citations

Select item 24355457 73.

Immune modulations during chemoimmunotherapy & novel vaccine strategies - In metastatic melanoma and non small-cell lung cancer.

Iversen TZ.

Dan Med J. 2013 Dec;60(12):B4774.

PMID: 24355457 [PubMed - in process] Free Article

Related citations

Select item 24355090 74.

Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months.

Lazcano-Ponce E, Stanley M, Muñoz N, Torres L, Cruz-Valdez A, Salmerón J, Rojas R, Herrero R, Hernández-Ávila M.

Vaccine. 2013 Dec 16. pii: S0264-410X(13)01593-4. doi: 10.1016/j.vaccine.2013.11.059. [Epub ahead of print]

PMID: 24355090 [PubMed - as supplied by publisher]

Related citations

Select item 24355089 75.

Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers.

Werker GR, Sharif B, Sun H, Cooper C, Bansback N, Anis AH. 26

Vaccine. 2013 Dec 16. pii: S0264-410X(13)01701-5. doi: 10.1016/j.vaccine.2013.11.103. [Epub ahead of print]

PMID: 24355089 [PubMed - as supplied by publisher]

Related citations

Select item 24355030 76.

Lyme disease vaccination: safety first - Author's reply.

Lantos PM.

Lancet Infect Dis. 2014 Jan;14(1):13. doi: 10.1016/S1473-3099(13)70346-3. No abstract available.

PMID: 24355030 [PubMed - in process]

Related citations

Select item 24355029 77.

Lyme disease vaccination: safety first - Authors' reply.

Barrett PN, Crowe BA, Wressnigg N, Portsmouth D, Aichinger G.

Lancet Infect Dis. 2014 Jan;14(1):12-3. doi: 10.1016/S1473-3099(13)70362-1. No abstract available.

PMID: 24355029 [PubMed - in process]

Related citations

Select item 24355028 78.

Lyme disease vaccination: safety first.

Stricker RB, Johnson L.

Lancet Infect Dis. 2014 Jan;14(1):12. doi: 10.1016/S1473-3099(13)70319-0. No abstract available.

PMID: 24355028 [PubMed - in process]

Related citations

Select item 24354949 79.

Barriers To The Vaccination Of Children And Adolescents And Possible Solutions.

Esposito S, Principi N, Cornaglia G; The ESCMID Vaccine Study Group (EVASG).

Clin Microbiol Infect. 2013 Dec 19. doi: 10.1111/1469-0691.12447. [Epub ahead of print]

PMID: 24354949 [PubMed - as supplied by publisher]

Related citations

Select item 24354913 80.

Vicious Viruses and Vigilant Vaccines: Effects of Linguistic Agency Assignment in Health Policy Advocacy.

Bell RA, McGlone MS, Dragojevic M.

J Health Commun. 2013 Dec 19. [Epub ahead of print]

PMID: 24354913 [PubMed - as supplied by publisher]

Related citations

Select item 24354908 81.

A novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma.

Figlin RA.

Immunotherapy. 2013 Dec 19. [Epub ahead of print]

PMID: 24354908 [PubMed - as supplied by publisher]

Related citations

Select item 24354891 82.

A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.

Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR.

Transl Neurodegener. 2013 Dec 19;2(1):25. doi: 10.1186/2047-9158-2-25.

PMID: 24354891 [PubMed] Free Article

Related citations

Select item 24354858 83.

Predicting H1N1 Vaccine Uptake and H1N1-Related Health Beliefs: The Role of Individual Difference in Consideration of Future Consequences.

Nan X, Kim J.

J Health Commun. 2013 Dec 19. [Epub ahead of print]

PMID: 24354858 [PubMed - as supplied by publisher]

Related citations

Select item 24354853 84.

A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice.

Inn KS, Lee GJ, Quan FS.

Immunol Invest. 2013 Dec 19. [Epub ahead of print]

PMID: 24354853 [PubMed - as supplied by publisher]

Related citations

Select item 24354839 85.

Influenza Vaccine Text Message Reminders for Urban, Low-Income Pregnant Women: A Randomized Controlled Trial.

Stockwell MS, Westhoff C, Kharbanda EO, Vargas CY, Camargo S, Vawdrey DK, Castaño PM.

Am J Public Health. 2013 Dec 19. [Epub ahead of print]

PMID: 24354839 [PubMed - as supplied by publisher]

Related citations

Select item 24354063 86.

[Immunomodulators and specific inactivated vaccines in urgent prophylaxis under experimental arboviral infection].

[No authors listed]

Vopr Virusol. 2013 Jul-Aug;58(4):35-9. Russian.

PMID: 24354063 [PubMed - in process]

Related citations

Select item 24354058 87.

[Vaccines against highly pathogenic influenza viruses of the avian origin].

[No authors listed]

Vopr Virusol. 2013 Jul-Aug;58(4):4-9. Russian.

PMID: 24354058 [PubMed - in process]

Related citations

Select item 24353756 88.

Correction: Cholera Vaccination Campaign Contributes to Improved Knowledge Regarding Cholera and Improved Practice Relevant to Waterborne Disease in Rural Haiti.

Aibana O, Franke MF, Teng JE, Hilaire J, Raymond M, Ivers LC.

PLoS Negl Trop Dis. 2013 Dec 13;7(12). doi: 10.1371/annotation/13f018ff-b71a-4c5e- a276-d4b4ae608fee.

PMID: 24353756 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 24353263 89.

MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers.

Hale SF, Camaione L, Lomaestro BM.

Ann Pharmacother. 2013 Dec 18. [Epub ahead of print]

PMID: 24353263 [PubMed - as supplied by publisher]

Related citations

Select item 24352476 90.

Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines.

Levy O, Netea MG.

Pediatr Res. 2013 Nov 6. doi: 10.1038/pr.2013.214. [Epub ahead of print]

PMID: 24352476 [PubMed - as supplied by publisher]

Related citations

Select item 24352450 91.

IMMUNOGENECITY OF NOVEL MUMPS VACCINE CANDIDATES GENERATED BY GENETIC MODIFICATION.

Xu P, Chen Z, Phan S, Pickar A, He B.

J Virol. 2013 Dec 18. [Epub ahead of print]

PMID: 24352450 [PubMed - as supplied by publisher]

Related citations

Select item 24352443 92.

Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine- Elicited Neutralizing Antibodies.

Decamp A, Hraber P, Bailer RT, Seaman MS, Ochsenbauer C, Kappes J, Gottardo R, Edlefsen P, Self S, Tang H, Greene K, Gao H, Daniell X, Sarzotti-Kelsoe M, Gorny MK, Zolla-Pazner S, Labranche CC, Mascola JR, Korber BT, Montefiori DC.

J Virol. 2013 Dec 18. [Epub ahead of print]

PMID: 24352443 [PubMed - as supplied by publisher]

Related citations

Select item 24352360 93.

Cancer vaccines: Material breach.

Dolgin E.

Nature. 2013 Dec 19;504(7480):S16-7. doi: 10.1038/504S16a. No abstract available.

PMID: 24352360 [PubMed - in process]

Related citations

Select item 24352315 94.

Universal influenza virus vaccines: need for clinical trials.

Krammer F, Palese P.

Nat Immunol. 2013 Dec 18;15(1):3-5. doi: 10.1038/ni.2761. No abstract available.

PMID: 24352315 [PubMed - in process]

Related citations

Select item 24352234 95.

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

Roederer M, Keele BF, Schmidt SD, Mason RD, Welles HC, Fischer W, Labranche C, Foulds KE, Louder MK, Yang ZY, Todd JP, Buzby AP, Mach LV, Shen L, Seaton KE, Ward BM, Bailer RT, Gottardo R, Gu W, Ferrari G, Alam SM, Denny TN, Montefiori DC, Tomaras GD, Korber BT, Nason MC, Seder RA, Koup RA, Letvin NL, Rao SS, Nabel GJ, Mascola JR.

Nature. 2013 Dec 18. doi: 10.1038/nature12893. [Epub ahead of print]

PMID: 24352234 [PubMed - as supplied by publisher]

Related citations

Select item 24352195 96.

Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery.

Nawwab Al-Deen FM, Selomulya C, Kong YY, Xiang SD, Ma C, Coppel RL, Plebanski M.

Gene Ther. 2013 Dec 19. doi: 10.1038/gt.2013.77. [Epub ahead of print]

PMID: 24352195 [PubMed - as supplied by publisher]

Related citations

Select item 24351795 97.

Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus.

Dayan GH, Pugachev K, Bevilacqua J, Lang J, Monath TP.

Viruses. 2013 Dec 9;5(12):3048-70. doi: 10.3390/v5123048.

PMID: 24351795 [PubMed - in process] Free Article

Related citations

Select item 24351755 98.

Novel Catanionic Surfactant Vesicle Vaccines Protect Mice against Francisella tularensis LVS and Confer Significant Partial Protection against F. tularensis Schu S4.

Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN. 33

Clin Vaccine Immunol. 2013 Dec 18. [Epub ahead of print]

PMID: 24351755 [PubMed - as supplied by publisher]

Related citations

Select item 24351391 99.

Measles outbreak among the Dukpa tribe of Buxa hills in West Bengal, India: Epidemiology and vaccine efficacy.

Bhuniya S, Maji D, Mandal D, Mondal N.

Indian J Public Health. 2013 Oct-Dec;57(4):272-5. doi: 10.4103/0019-557X.123273.

PMID: 24351391 [PubMed - in process]

Related citations

Select item 24350731 100.

The issue of mandatory vaccination for healthcare workers in Europe.

Galanakis E, D'Ancona F, Jansen A, Lopalco PL; VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points4.

Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print]

PMID: 24350731 [PubMed - as supplied by publisher]

Related citations

Select item 24350687 101.

Live attenuated vaccine: the first clinically approved dengue vaccine?

Fink K, Shi PY.

Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print]

PMID: 24350687 [PubMed - as supplied by publisher]

Related citations

Select item 24350616 102.

High Mobility group box 1 (HMGB1) acts as an adjuvant for tuberculosis subunit vaccines.

Grover A, Troudt J, Foster C, Basaraba R, Izzo A.

Immunology. 2013 Dec 18. doi: 10.1111/imm.12236. [Epub ahead of print]

PMID: 24350616 [PubMed - as supplied by publisher]

Related citations

Select item 24350614 103.

Second-generation prophylactic HPV vaccines: successes and challenges.

Tyler M, Tumban E, Chackerian B.

Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print]

PMID: 24350614 [PubMed - as supplied by publisher]

Related citations

Select item 24350587 104.

Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.

Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print]

PMID: 24350587 [PubMed - as supplied by publisher]

Related citations

AMEDEO - Vaccines Publicaciones (23 - 12 - 2013): 71 artículos nuevos.

Vacunas Meningococo (Neisseria meningitidis)

2. SIMON MS, Weiss D, Gulick RM. Invasive meningococcal disease in men who have sex with men. Ann Intern Med. 2013;159:300-1. PubMed: www.amedeo.com/p2.php?id=23778867&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/23778867

24. MARTINON-TORRES F. Immunisation against meningococcus B: the case of Spain. Lancet. 2013;382:1552-3. PubMed: www.amedeo.com/p2.php?id=24209823&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24209823

Vacunas Neumococo (Streptococcus pneumoniae)

6. GRABENSTEIN JD, Weber DJ. Pneumococcal Serotype Diversity among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24344141&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24344141

32. HALPERIN SA, Tapiero B, Dionne M, Meekison W, et al. Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J. 2014;33:73-80. PubMed: www.amedeo.com/p2.php?id=24346596&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24346596

38. LOO JD, Conklin L, Deloria Knoll M, Fleming-Dutra KE, et al. Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules. Pediatr Infect Dis J. 2014;33 Suppl 2:S182-7. PubMed: www.amedeo.com/p2.php?id=24336060&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336060

39. WHITNEY CG, Goldblatt D, O'Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infect Dis J. 2014;33 Suppl 2:S172-81. PubMed: www.amedeo.com/p2.php?id=24336059&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336059

40. LOO JD, Conklin L, Fleming-Dutra KE, Knoll MD, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33 Suppl 2:S161-71. PubMed: www.amedeo.com/p2.php?id=24336058&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336058

41. FLEMING-DUTRA KE, Conklin L, Loo JD, Knoll MD, et al. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage. Pediatr Infect Dis J. 2014;33 Suppl 2:S152-60. PubMed: www.amedeo.com/p2.php?id=24336057&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336057

42. LOO JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J. 2014;33 Suppl 2:S140-51. PubMed: www.amedeo.com/p2.php?id=24336056&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336056

43. PARK DE, Johnson TS, Nonyane BA, Chandir S, et al. The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity. Pediatr Infect Dis J. 2014;33 Suppl 2:S130-9. PubMed: www.amedeo.com/p2.php?id=24336055&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336055

44. DELORIA KNOLL M, Park DE, Johnson TS, Chandir S, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity. Pediatr Infect Dis J. 2014;33 Suppl 2:S119-29. PubMed: www.amedeo.com/p2.php?id=24336054&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336054

45. CONKLIN L, Loo JD, Kirk J, Fleming-Dutra KE, et al. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children. Pediatr Infect Dis J. 2014;33 Suppl 2:S109-18. PubMed: www.amedeo.com/p2.php?id=24336053&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336053

46. O'BRIEN KL, Goldblatt D, Whitney CG. Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules? Pediatr Infect Dis J. 2014;33 Suppl 2:S107-8. PubMed: www.amedeo.com/p2.php?id=24336052&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24336052

51. GONCALVES VM, Dias WO, Ivana CB, Liberman C, et al. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability. Vaccine. 2013 Dec 13. pii: S0264-410X(13)01693. PubMed: www.amedeo.com/p2.php?id=24342254&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24342254

54. ZUCCOTTI G, Mameli C, Daprai L, Garlaschi ML, et al. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Vaccine. 2013 Dec 13. pii: S0264-410X(13)01697. PubMed: www.amedeo.com/p2.php?id=24342249&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/24342249

Vacunas Fiebre tifoidea (Salmonella typhi)

56. PAKKANEN SH, Kantele JM, Herzog C, Kantele A, et al. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae. Vaccine. 2013 Dec 13. pii: S0264-410X(13)01690. PubMed: www.amedeo.com/p2.php?id=24342246&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24342246

Vacunas, otras

1. BUDENHOLZER B. HPV vaccination reduced cytologic abnormalities compared with control vaccination in young women. Ann Intern Med. 2013;159:JC4. PubMed: www.amedeo.com/p2.php?id=24343409&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24343409

2. SIMON MS, Weiss D, Gulick RM. Invasive meningococcal disease in men who have sex with men. Ann Intern Med. 2013;159:300-1. PubMed: www.amedeo.com/p2.php?id=23778867&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23778867

3. TRAVASSO C. Only a sixth of animal bite victims in India get antirabies treatment. BMJ. 2013;347:f6040. PubMed: www.amedeo.com/p2.php?id=24100655&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24100655

4. XU Y, Liu H, Wang Y, Hao R, et al. The next step in controlling HBV in China. BMJ. 2013;347:f4503. PubMed: www.amedeo.com/p2.php?id=23861426&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23861426

5. TOOKEY PA, Bedford H, Peckham CS. Act now to prevent re-emergence of congenital rubella. BMJ. 2013;347:f4498. PubMed: www.amedeo.com/p2.php?id=23861425&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23861425

6. GRABENSTEIN JD, Weber DJ. Pneumococcal Serotype Diversity among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake.

Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24344141&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24344141

7. BRUMMETT AM, Navratil AR, Bryan JD, Woolard MD, et al. Janus Kinase 3 Activity is Necessary for the Phosphorylation of Cytosolic Phospholipase A2 and Prostaglandin E2 Synthesis by Macrophages infected with Francisella tularensis Live Vaccine Strain. Infect Immun. 2013. PubMed: www.amedeo.com/p2.php?id=24343645&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24343645

8. SHI L, Wang JM, Ren JP, Cheng YQ, et al. KLRG1 Impairs CD4+ T Cell Responses via p16ink4a and p27kip1 Pathways: Role in Hepatitis B Vaccine Failure in Individuals with Hepatitis C Virus Infection. J Immunol. 2013. PubMed: www.amedeo.com/p2.php?id=24337749&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24337749

9. FARKAS AM, Finn OJ. Novel Mechanisms Underlying the Immediate and Transient Global Tolerization of Splenic Dendritic Cells after Vaccination with a Self-Antigen. J Immunol. 2013. PubMed: www.amedeo.com/p2.php?id=24337381&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24337381

10. FEDSON DS. Influenza vaccination effectiveness, unmeasured confounding and immunomodulatory treatment. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24342988&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24342988

11. MENGEL M, Mintz E, Nair GB, Gessner BD, et al. Editorial committee introduction. J Infect Dis. 2013;208 Suppl 1:S1-3. PubMed: www.amedeo.com/p2.php?id=24101637&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24101637

12. LANG KUHS KA, Gonzalez P, Struijk L, Castro F, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis. 2013;208:1643-52. PubMed: www.amedeo.com/p2.php?id=24014882&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24014882

13. LAHEY T, Czechura T, Crabtree S, Arbeit RD, et al. Greater pre-existing interferon gamma responses to mycobacterial antigens are associated with lower bacillary load during HIV-associated tuberculosis. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=23908490&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23908490

14. TALAAT KR, Karron RA, Thumar B, McMahon BA, et al. Experimental infection of adults with recombinant wild-type human metapneumovirus. J Infect Dis. 2013;208:1669-78. PubMed: www.amedeo.com/p2.php?id=23908489&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23908489

15. DUCHARME R, Benchimol EI, Deeks SL, Hawken S, et al. Validation of diagnostic codes for intussusception and quantification of childhood intussusception incidence in Ontario, Canada: a population-based study. J Pediatr. 2013;163:1073-9. PubMed: www.amedeo.com/p2.php?id=23809052&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23809052

16. XU P, Chen Z, Phan S, Pickar A, et al. IMMUNOGENECITY OF NOVEL MUMPS VACCINE CANDIDATES GENERATED BY GENETIC MODIFICATION. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24352450&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24352450

17. DECAMP A, Hraber P, Bailer RT, Seaman MS, et al. Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24352443&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24352443

18. ZAPATA JC, Goicochea M, Nadai Y, Eyzaguirre LM, et al. Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24335292&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24335292

19. KHAYAT R, Lee JH, Julien JP, Cupo A, et al. Structural characterization of cleaved, soluble human immunodeficiency virus type-1 envelope glycoprotein trimers. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=23824817&s=vac&pm=badc2a9eebb0fad

ABSTRACT available Share: http://m.amedeo.com/23824817

20. BRUDER JT, Chen P, Semenova E, Thomas CA, et al. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors. J Virol. 2013;87:9661-71. PubMed: www.amedeo.com/p2.php?id=23824800&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23824800

21. CERVASI B, Carnathan DG, Sheehan KM, Micci L, et al. Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac. J Virol. 2013;87:9420-30. PubMed: www.amedeo.com/p2.php?id=23804645&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23804645

22. LI Z, Gabbard JD, Mooney A, Chen Z, et al. Efficacy of Parainfluenza virus 5 mutants expressing HA from H5N1 influenza A virus in mice. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=23804633&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23804633

23. TULCHINSKY TH, Ramlawi A, Abdeen Z, Grotto I, et al. Polio lessons 2013: Israel, the West Bank, and Gaza. Lancet. 2013;382:1611-2. PubMed: www.amedeo.com/p2.php?id=24238546&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24238546

24. MARTINON-TORRES F. Immunisation against meningococcus B: the case of Spain. Lancet. 2013;382:1552-3. PubMed: www.amedeo.com/p2.php?id=24209823&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24209823

25. Seasonal influenza vaccination coverage among women who delivered a live-born infant - 21 States and new york city, 2009-10 and 2010-11 influenza seasons. MMWR Morb Mortal Wkly Rep. 2013;62:1001-4. PubMed: www.amedeo.com/p2.php?id=24336132&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336132

26. Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2013;62:997-1000.

PubMed: www.amedeo.com/p2.php?id=24336131&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336131

27. JAIN VK, Rivera L, Zaman K, Espos RA Jr, et al. Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children. N Engl J Med. 2013. PubMed: www.amedeo.com/p2.php?id=24328444&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24328444

28. BADEN LR. For an Influenza Vaccine, Are Two Bs Better Than One? N Engl J Med. 2013. PubMed: www.amedeo.com/p2.php?id=24328439&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24328439

29. MUNDEL T, Orenstein WA. No country is safe without global eradication of poliomyelitis. N Engl J Med. 2013;369:2045-6. PubMed: www.amedeo.com/p2.php?id=24256383&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24256383

30. LUO HM, Zhang Y, Wang XQ, Yu WZ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369:1981-90. PubMed: www.amedeo.com/p2.php?id=24256377&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24256377

31. IROH TAM PY, Hanisch BR, Klammer K, Devries AS, et al. Measles Vaccine Strain From the Skin Rash of a DiGeorge Patient Receiving Tumor Necrosis Factor Inhibitor. Pediatr Infect Dis J. 2014;33:117. PubMed: www.amedeo.com/p2.php?id=24346604&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24346604

33. NGENDAHAYO E, Bonane A, Ntakiyiruta G, Munyanshongore A, et al. Preparing for Safety Monitoring After Rotavirus Vaccine Implementation: A

Retrospective Review of Intussusception Cases among Children at a Large Teaching Hospital in Rwanda, 2009-2012. Pediatr Infect Dis J. 2014;33 Suppl 1:S99-S103. PubMed: www.amedeo.com/p2.php?id=24343624&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24343624

34. MPABALWANI EM, Chitambala P, Chibumbya JN, Matapo B, et al. Intussusception incidence rates in 9 zambian hospitals, 2007-2011: prerotavirus vaccine introduction. Pediatr Infect Dis J. 2014;33 Suppl 1:S94-8. PubMed: www.amedeo.com/p2.php?id=24343623&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24343623

35. NGABO F, Gatera M, Karema C, Donnen P, et al. Can Routinely Collected National Data on Childhood Morbidity and Mortality from Diarrhea be Used to Monitor Health Impact of Rotavirus Vaccination in Africa?: Examination of Pre-Vaccine Baseline Data from Rwanda. Pediatr Infect Dis J. 2014;33 Suppl 1:S89-93. PubMed: www.amedeo.com/p2.php?id=24343621&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24343621

36. MUSTAFA A, Makki A, Siddig O, Haithami S, et al. Baseline burden of rotavirus disease in Sudan to monitor the impact of vaccination. Pediatr Infect Dis J. 2014;33 Suppl 1:S23-7. PubMed: www.amedeo.com/p2.php?id=24343609&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24343609

37. MWENDA JM, Tate JE, Steele AD, Parashar UD, et al. Preparing for the Scale-up of Rotavirus Vaccine Introduction in Africa: Establishing Surveillance Platforms to Monitor Disease Burden and Vaccine Impact. Pediatr Infect Dis J. 2014;33 Suppl 1:S1-5. PubMed: www.amedeo.com/p2.php?id=24343605&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24343605

ABSTRACT available Share: http://m.amedeo.com/24336059

46. O'BRIEN KL, Goldblatt D, Whitney CG.

Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules? Pediatr Infect Dis J. 2014;33 Suppl 2:S107-8. PubMed: www.amedeo.com/p2.php?id=24336052&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24336052

47. Recommendations for Prevention and Control of Influenza in Children, 2013-2014. Pediatrics. 2013. PubMed: www.amedeo.com/p2.php?id=23999962&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23999962

48. KONG L, Giang E, Nieusma T, Kadam RU, et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science. 2013;342:1090-4. PubMed: www.amedeo.com/p2.php?id=24288331&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24288331

49. LARSON C. Public health. Tense vigil in China as nasty flu virus stirs back to life. Science. 2013;342:1031. PubMed: www.amedeo.com/p2.php?id=24288311&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24288311

50. ROBERTS L. Infectious disease. Israel's silent polio epidemic breaks all the rules. Science. 2013;342:679-80. PubMed: www.amedeo.com/p2.php?id=24202150&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24202150

52. BRITO BP, Perez AM, Capozzo AV. Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle. Vaccine. 2013 Dec 13. pii: S0264-410X(13)01705. PubMed: www.amedeo.com/p2.php?id=24342253&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24342253

53. LIN CJ, Zimmerman RK, Nowalk MP, Huang HH, et al. Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01691. PubMed: www.amedeo.com/p2.php?id=24342252&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24342252

55. JANG YH, Lee EY, Byun YH, Jung EJ, et al. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Vaccine. 2013 Dec 13. pii: S0264-410X(13)01694. PubMed: www.amedeo.com/p2.php?id=24342248&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24342248

57. STEIL BP, Jorquera P, Westdijk J, Bakker WA, et al. A mucosal adjuvant for the inactivated poliovirus vaccine. Vaccine. 2013 Dec 12. pii: S0264-410X(13)01696. PubMed: www.amedeo.com/p2.php?id=24333345&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24333345

58. RINALDI S, Zangari P, Cotugno N, Manno EC, et al. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza. Vaccine. 2013 Dec 12. pii: S0264-410X(13)01706. PubMed: www.amedeo.com/p2.php?id=24333344&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24333344

59. DHEDIN N, Krivine A, Le Corre N, Mallet A, et al. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients. Vaccine. 2013 Dec 11. pii: S0264-410X(13)01662. PubMed: www.amedeo.com/p2.php?id=24333120&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/24333120

60. POLJAK M, Seme K, Maver PJ, Kocjan BJ, et al. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in central and eastern europe. Vaccine. 2013;31 Suppl 7:H59-70. PubMed: www.amedeo.com/p2.php?id=24332298&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24332298

61. ROGOVSKAYA SI, Shabalova IP, Mikheeva IV, Minkina GN, et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia. Vaccine. 2013;31 Suppl 7:H46-58. PubMed: www.amedeo.com/p2.php?id=24332297&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24332297

62. JUMAAN AO, Ghanem S, Taher J, Braikat M, et al. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended middle East and north Africa region. Vaccine. 2013;31 Suppl 6:G58-64. PubMed: www.amedeo.com/p2.php?id=24331821&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24331821

63. SANKARANARAYANAN R, Anorlu R, Sangwa-Lugoma G, Denny LA, et al. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-saharan Africa. Vaccine. 2013;31 Suppl 5:F47-52. PubMed: www.amedeo.com/p2.php?id=24331747&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24331747

64. HADLER SC, Fuqiang C, Averhoff F, Taylor T, et al. The impact of hepatitis B vaccine in China and in the China GAVI Project. Vaccine. 2013;31 Suppl 9:J66-72. PubMed: www.amedeo.com/p2.php?id=24331023&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24331023

65. HUTIN Y, Hennessey K, Cairns L, Zhang Y, et al. Improving hepatitis B vaccine timely birth dose coverage: Lessons from five demonstration projects in China, 2005-2009. Vaccine. 2013;31 Suppl 9:J49-55. PubMed: www.amedeo.com/p2.php?id=24331021&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24331021

66. CUI F, Liang X, Gong X, Chen Y, et al. Preventing hepatitis B though universal vaccination: Reduction of inequalities through the GAVI China project. Vaccine. 2013;31 Suppl 9:J29-35. PubMed: www.amedeo.com/p2.php?id=24331017&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24331017

67. CALVO-PINILLA E, de la Poza F, Gubbins S, Mertens PP, et al. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation. Virus Res. 2013 Dec 12. pii: S0168-1702(13)00431. PubMed: www.amedeo.com/p2.php?id=24333835&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24333835

68. Progress towards poliomyelitis eradication in Pakistan, January 2012- September 2013. Wkly Epidemiol Rec. 2013;88:501-8. PubMed: www.amedeo.com/p2.php?id=24319789&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24319789

69. KRAMMER F, Palese P. Universal influenza virus vaccines: need for clinical trials. Nat Immunol. 2013;15:3-5. PubMed: www.amedeo.com/p2.php?id=24352315&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24352315

70. LI S, Rouphael N, Duraisingham S, Romero-Steiner S, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2013 Dec 15. doi: 10.1038/ni.2789. PubMed: www.amedeo.com/p2.php?id=24336226&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336226

71. FAUCI AS, Folkers GK, Dieffenbach CW. HIV-AIDS: much accomplished, much to do. Nat Immunol. 2013;14:1104-7. PubMed: www.amedeo.com/p2.php?id=24145780&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24145780

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20131217->20131227): 4 patentes recuperadas.

Adyuvantes

3 8,609,114 Methods of using a vaccine composition containing

synthetic adjuvant

Vacunas, otras

PAT. Title NO.

1 8,613,936 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements

comprising multiple elements

2 8,609,392 Method for orthopoxvirus production and purification

3 8,609,114 Methods of using a vaccine composition containing

synthetic adjuvant

4 8,609,108 Gamma-glutamyl transpeptidase attenuated Francisella

European Patent Office (EPO)

Acumulado entre el 17 y el 27 de diciembre de 2013: 12 patentes recuperadas.

Vacuna Tuberculosis (Mycobacterium tuberculosis)

7. RECOMBINANT MYCOBCTERIUM AS A VACCINE

Publication info: US2013337011 (A1) 2013-12-19

Vacunas, otras

1. Development of dengue virus vaccine components

AU2013263788 (A1) 2013-12-19 Publication info:

2. In situ antigen-generating cancer vaccine

AU2012261848 (A1) 2013-12-19 Publication info:

3. Thermostable vaccine compositions and methods of preparing same

AU2012255132 (A1) 2013-12-19 Publication info:

4. Ureaplasma vaccine and anitibody for prevention and treatment of human, animal and cell culture infection

AU2012249264 (A1) 2013-12-19 Publication info:

5. Method for Computer-Aided Vaccine Discovery

US2013338988 (A1) 2013-12-19 Publication info:

6. CHIMERIC DNA VACCINE COMPOSITIONS AND METHODS OF USE

US2013337009 (A1) 2013-12-19 Publication info:

7. RECOMBINANT MYCOBCTERIUM AS A VACCINE

US2013337011 (A1) 2013-12-19 Publication info:

8. ADENOVIRAL VECTOR-BASED DENGUE FEVER VACCINE

US2013337008 (A1) 2013-12-19 Publication info:

9. CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE

WO2013188627 (A2) 2013-12-19 Publication info:

10. GENETICALLY MODIFIED SCHMALLENBERG VIRUS (SBV) FOR USE AS VACCINE

WO2013186539 (A1) 2013-12-19 Publication info:

11. INFLUENZA VACCINE

WO2013185177 (A1) 2013-12-19 Publication info:

12. NUCLEIC ACID MOLECULE ENCODING HEPATITIS B VIRUS CORE PROTEIN AND VACCINE COMPRISING THE SAME

EP2672992 (A1) 2013-12-18 Publication info:

TABLAS DE CONTENIDO

Revista Vaccine

New Articles in Press, 16 December-22 December 2013.

1. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model Original Research Article

Available online 21 December 2013 Anja Weinreich Olsen, Peter Andersen, Frank Follmann

2. Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: Opportunities to engage the private sector Original Research Article

Available online 19 December 2013 Minal K. Patel, Rosario Z. Capeding, Joyce U. Ducusin, Maricel de Quiroz Castro, Luzviminda C. Garcia, Karen Hennessey

3. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals Original Research Article

Available online 18 December 2013 Inna G. Ovsyannikova, Sarah J. White, Beth R. Larrabee, Diane E. Grill, Robert M. Jacobson, Gregory A. Poland

4. Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Original Research Article

Available online 16 December 2013 Eduardo Lazcano-Ponce, Margaret Stanley, Nubia Muñoz, Leticia Torres, Aurelio Cruz-Valdez, Jorge Salmerón, Rosalba Rojas, Rolando Herrero, Mauricio Hernández-Ávila

5. Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children Original Research Article

Available online 16 December 2013 Qingfu Xu, Michael E. Pichichero

6. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers Original Research Article

Available online 16 December 2013 Gregory R. Werker, Behnam Sharif, Huiying Sun, Curtis Cooper, Nick Bansback, Aslam H. Anis

Volume 32, Issue 3, Pages 311-432, 9 January 2014.

1. Editorial Board/Aims and Scope

Pages CO2

Reviews

2. Novel vaccination approaches against equine alphavirus encephalitides Review Article

Pages 311-319 Mariano Carossino, Etienne Thiry, Ana de la Grandière, Maria E. Barrandeguy

3. Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization program Review Article

Pages 320-326 Proma Paul, Anthony Fabio

4. Nanoparticle vaccines Review Article

Pages 327-337 Liang Zhao, Arjun Seth, Nani Wibowo, Chun-Xia Zhao, Neena Mitter, Chengzhong Yu, Anton P.J. Middelberg

Regular papers

5. Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines Original Research Article

Pages 338-344 Helen Marshall, Michelle Clarke, Thomas Sullivan

6. Assessing vaccination coverage in infants, survey studies versus the Flemish immunisation register: Achieving the best of both worlds Original Research Article

Pages 345-349 Tessa Braeckman, Tinne Lernout, Geert Top, Annick Paeps, Mathieu Roelants, Karel Hoppenbrouwers, Pierre Van Damme, Heidi Theeten

7. Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain Original Research Article

Pages 350-354 Rodrigo Jiménez-García, Cristina Rodríguez-Rieiro, Valentín Hernandez-

Barrera, Pilar Carrasco Garrido, Ana López de Andres, María D. Esteban- Vasallo, Maria Felicitas Domínguez-Berjón, Jenaro Astray-Mochales

8. One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge Original Research Article

Pages 355-362 Miriam Klausberger, Monika Wilde, Dieter Palmberger, Rong Hai, Randy A. Albrecht, Irina Margine, Ariana Hirsh, Adolfo García-Sastre, Reingard Grabherr, Florian Krammer

9. Potential for a live red seabream iridovirus (RSIV) vaccine in rock bream Oplegnathus fasciatus at a low rearing temperature Original Research Article

Pages 363-368 So-Young Oh, Myung-Joo Oh, Toyohiko Nishizawa

10. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City Original Research Article

Pages 369-374 Kara A. Livingston, Jennifer B. Rosen, Jane R. Zucker, Christopher M. Zimmerman

11. Alterations in immunodominance of Streptococcus mutans AgI/II: Lessons learned from immunomodulatory antibodies Original Research Article

Pages 375-382 Rebekah A. Robinette, Kyle P. Heim, Monika W. Oli, Paula J. Crowley, William P. McArthur, L. Jeannine Brady

12. Ascaridia galli infection influences the development of both humoral and cell- mediated immunity after Newcastle Disease vaccination in chickens Original Research Article

Pages 383-392 Janne Pleidrup, Tina S. Dalgaard, Liselotte R. Norup, Anders Permin, Torben W. Schou, Kerstin Skovgaard, Dorte F. Vadekær, Gregers Jungersen, Poul Sørensen, Helle R. Juul-Madsen

13. Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV Original Research Article

Pages 393-400 José M. Rojas, Héctor Moreno, Aída García, Juan C. Ramírez, Noemí Sevilla, Verónica Martín

14. Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo Original Research Article

Pages 401-408 Chia-Chen Pi, Ching-Liang Chu, Chu-Ying Lu, Yu-Jing Zhuang, Cheng-Li Wang, Yao-Hsuan Yu, Hui-Yi Wang, Chih-Chung Lin, Chun-Jen Chen

15. Cervical cancer and HPV: Awareness and vaccine acceptability among parents in Morocco Original Research Article

Pages 409-416 Mustapha Mouallif, Harriet L. Bowyer, Soukaina Festali, Adelin Albert, Younes Filali-Zegzouti, Samuel Guenin, Philippe Delvenne, Jo Waller, Moulay Mustapha Ennaji

16. Decreased immune response to pneumococcal conjugate vaccine after 23- valent pneumococcal polysaccharide vaccine in children Original Research Article

Pages 417-424 Sigurveig Th. Sigurdardottir, Kimberly J. Center, Katrin Davidsdottir, Vilhjalmur A. Arason, Bjorn Hjalmarsson, Ragnheidur Elisdottir, Gunnhildur Ingolfsdottir, Robert Northington, Daniel A. Scott, Ingileif Jonsdottir

17. Construction of a recombinant-attenuated Salmonella Enteritidis strain secreting Escherichia coli heat-labile enterotoxin B subunit protein and its immunogenicity and protection efficacy against salmonellosis in chickens Original Research Article

Pages 425-431 Rahul M. Nandre, John Hwa Lee

